NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,318 | -53.4% | 9,174 | -38.4% | 0.00% | – |
| Q2 2023 | $378,317 | +3.6% | 14,883 | +47.3% | 0.00% | – |
| Q1 2023 | $365,285 | +546.9% | 10,104 | +608.6% | 0.00% | – |
| Q4 2022 | $56,469 | -83.2% | 1,426 | -80.2% | 0.00% | – |
| Q3 2022 | $337,000 | -8.2% | 7,191 | -13.9% | 0.00% | – |
| Q2 2022 | $367,000 | -66.1% | 8,355 | -44.2% | 0.00% | – |
| Q1 2022 | $1,083,000 | -45.4% | 14,978 | -38.7% | 0.00% | – |
| Q4 2021 | $1,982,000 | -40.7% | 24,449 | -14.8% | 0.00% | -100.0% |
| Q3 2021 | $3,342,000 | -44.2% | 28,708 | -20.6% | 0.00% | 0.0% |
| Q2 2021 | $5,991,000 | -7.0% | 36,145 | -21.7% | 0.00% | 0.0% |
| Q1 2021 | $6,440,000 | -36.4% | 46,170 | -21.0% | 0.00% | -50.0% |
| Q4 2020 | $10,121,000 | +47.9% | 58,467 | +19.0% | 0.00% | 0.0% |
| Q3 2020 | $6,843,000 | -15.3% | 49,129 | -27.3% | 0.00% | 0.0% |
| Q2 2020 | $8,077,000 | -4.3% | 67,615 | -19.9% | 0.00% | -33.3% |
| Q1 2020 | $8,439,000 | +4.5% | 84,402 | +22.8% | 0.00% | +50.0% |
| Q4 2019 | $8,079,000 | +166.4% | 68,745 | +94.8% | 0.00% | +100.0% |
| Q3 2019 | $3,033,000 | +52.0% | 35,285 | +14.6% | 0.00% | 0.0% |
| Q2 2019 | $1,996,000 | -10.0% | 30,777 | -13.3% | 0.00% | 0.0% |
| Q1 2019 | $2,218,000 | -43.2% | 35,500 | -64.7% | 0.00% | 0.0% |
| Q4 2018 | $3,908,000 | -67.7% | 100,470 | -52.7% | 0.00% | -66.7% |
| Q3 2018 | $12,103,000 | -88.9% | 212,332 | -84.5% | 0.00% | -90.6% |
| Q2 2018 | $109,153,000 | +52.9% | 1,366,980 | +66.0% | 0.03% | +52.4% |
| Q1 2018 | $71,378,000 | +19.0% | 823,579 | -5.2% | 0.02% | +23.5% |
| Q4 2017 | $60,003,000 | -39.0% | 869,089 | -19.7% | 0.02% | -43.3% |
| Q3 2017 | $98,338,000 | +35.7% | 1,082,072 | +11.1% | 0.03% | +30.4% |
| Q2 2017 | $72,478,000 | +29.9% | 973,783 | +63.6% | 0.02% | +27.8% |
| Q1 2017 | $55,786,000 | +40.9% | 595,361 | +9.3% | 0.02% | +28.6% |
| Q4 2016 | $39,591,000 | -18.3% | 544,871 | +17.4% | 0.01% | -22.2% |
| Q3 2016 | $48,460,000 | -57.2% | 464,230 | -69.8% | 0.02% | -59.1% |
| Q2 2016 | $113,228,000 | +44.5% | 1,535,107 | +10.3% | 0.04% | +41.9% |
| Q1 2016 | $78,333,000 | +99.2% | 1,392,314 | +139.0% | 0.03% | +93.8% |
| Q4 2015 | $39,331,000 | +60.3% | 582,588 | +10.2% | 0.02% | +60.0% |
| Q3 2015 | $24,535,000 | +12.0% | 528,904 | +29.8% | 0.01% | +25.0% |
| Q2 2015 | $21,909,000 | +5821.4% | 407,605 | +5197.7% | 0.01% | – |
| Q1 2015 | $370,000 | +189.1% | 7,694 | +134.0% | 0.00% | – |
| Q4 2014 | $128,000 | – | 3,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |